Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
2(50.0%)
4Total
N/A(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01909349Not ApplicableCompleted

Web-based Aftercare Intervention for Cardiac Patients

Role: collaborator

NCT01296776Phase 3Completed

Effect of Electromyostimulation on Bone

Role: collaborator

NCT01406730Phase 3Completed

Running Effect on Cardiovascular and Muscular Parameters

Role: collaborator

NCT00599742Not ApplicableUnknown

Comorbidity Between Balance and Childhood Anxiety

Role: collaborator

NCT00469794Unknown

The Significance of Arrhythmias in Athletes

Role: collaborator

All 5 trials loaded